A Method Of Purifying A Binding Protein Produced By A Host Cell

Sanofi
Application Awaiting Examination App No 202318039356 Biotechnology

Patent information

IP India · live record
Application number
202318039356
Filing date
08 June 2023
Status
Application Awaiting Examination
Publication number
32/2024
Publication type
INA
Invention field
Biotechnology

Abstract

A method of purifying a binding protein produced by a host cell, comprising: (a) producing in a host cell a binding protein comprising four polypeptide chains that fonn three antigen binding sites that specifically bind one or more antigen targets or target proteins, wherein a first polypeptide chain comprises a structure represented by the formula: VLz-LJ-Vu-Lz-CL [1] and a second polypeptide chain comprises a structure represented by the fommla: VH1-L3-VH2-L4-CHt-hinge-CH2-Cm [II] and a third polypeptide chain comprises a structure represented by the formula: [III] and a fourth polypeptide chain comprises a structure represented by the fonnula: V13-CL [IV] Vu is a first immunoglobulin light chain variable domain; Vu is a second immwJOglobuli.tl light chai.t1 variable domain; VLJ is a third immunoglobulin light chain variable domain; VHt is a first immunoglobulin heavy chain variable domain; VH2 is a second illllllunoglobulinheavy chain variable domain; VHJ is a thi.t·d immunoglobulin heavy chain variable domain; CL is an immunoglobulin light chain constant domain; CH.1 is an immunoglobulin CRt heavy chain constant domain; Cm is an immunoglobulin CH2 heavy chain constant domain; Cm is an immunoglobulin Cm heavy chain constant domain; hinge is an immunoglobulin hinge region connecting the Cm and Cm domains; and L 1, Lz, L3 and L4 are amino acid linkers; wherein the polypeptide of fonnula 1 and the polypeptide of fonnula II form a cross-over light chainheavy chain pair; wherein only one of the Cm domain of the second polypeptide chain and the CH3 domain of the third polypeptide chain comprises amino acid substitutions at positions corresponding to positions 435 and 436 of humanlgGl or lgG4 according to EU Index, wherein the amino acid substitutions are H435R and Y436F; (b) contacting the binding protein produced in (a) with Protein A; and (c) eluti.t1g the binding protein from Protein A under cooditious sllitable for isolating the binding pruldu away from binding proteins comprising either 0 or 2 Cm domains comprising the amino acid substitutions are H435R and Y436F, thereby purifying the binding protein.

Applicants

1
France
SANOFI 54 RUE LA BOETIE, PARIS FRANCE 75008

Inventors

11
U.S.A.
YANG, Zhi-YongC/O SANOFI 55 CORPORATE DRIVE, MAIL CODE 55A-505A , BRIDGEWATER, NJ UNITED STATES OF AMERICA 08807
U.S.A.
NABEL, Gary, J.C/O SANOFI 55 CORPORATE DRIVE, MAIL CODE 55A-505A BRIDGEWATER, NJ UNITED STATES OF AMERICA 08807
U.S.A.
WU, LanC/O SANOFI 55 CORPORATE DRIVE, MAIL CODE 55A-505A BRIDGEWATER, NJ UNITED STATES OF AMERICA 08807
U.S.A.
SEUNG, EdwardC/O SANOFI 55 CORPORATE DRIVE, MAIL CODE 55A-505A BRIDGEWATER, NJ UNITED STATES OF AMERICA 08807
U.S.A.
WEI, RonnieC/O SANOFI 55 CORPORATE DRIVE, MAIL CODE 55A-505A BRIDGEWATER, NJ UNITED STATES OF AMERICA 08807
Germany
BENINGA, JochenC/O SANOFI-AVENTIS DEUTSCHLAND GMBH FRANKFURT AM MAIN GERMANY 65926
Germany
RAO, ErcoleC/O SANOFI-AVENTIS DEUTSCHLAND GMBH FRANKFURT AM MAIN GERMANY 65926
Germany
LEUSCHNER, Wulf DirkC/O SANOFI-AVENTIS DEUTSCHLAND GMBH FRANKFURT AM MAIN GERMANY 65926
Germany
BEIL, ChristianC/O SANOFI-AVENTIS DEUTSCHLAND GMBH FRANKFURT AM MAIN GERMANY 65926
Germany
LANGE, ChristianC/O SANOFI-AVENTIS DEUTSCHLAND GMBH FRANKFURT AM MAIN GERMANY 65926
Germany
CORVEY, CarstenC/O SANOFI-AVENTIS DEUTSCHLAND GMBH FRANKFURT AM MAIN GERMANY 65926

Specification

Show full textCollapse

Description:as uploaded , Claims:as uploaded

Documents

Sign in to open
Application documents
1 202318039356-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [08-06-2023(online)].pdf 08 Jun 2023
2 202318039356-STATEMENT OF UNDERTAKING (FORM 3) [08-06-2023(online)].pdf 08 Jun 2023
3 202318039356-Sequence Listing in txt [08-06-2023(online)].txt 08 Jun 2023
4 202318039356-Sequence Listing in PDF [08-06-2023(online)].pdf 08 Jun 2023
5 202318039356-REQUEST FOR EXAMINATION (FORM-18) [08-06-2023(online)].pdf 08 Jun 2023
6 202318039356-POWER OF AUTHORITY [08-06-2023(online)].pdf 08 Jun 2023
7 202318039356-FORM 18 [08-06-2023(online)].pdf 08 Jun 2023
8 202318039356-FORM 1 [08-06-2023(online)].pdf 08 Jun 2023
9 202318039356-DRAWINGS [08-06-2023(online)].pdf 08 Jun 2023
10 202318039356-DECLARATION OF INVENTORSHIP (FORM 5) [08-06-2023(online)].pdf 08 Jun 2023
11 202318039356-COMPLETE SPECIFICATION [08-06-2023(online)].pdf 08 Jun 2023
12 202318039356-Proof of Right [10-11-2023(online)].pdf 10 Nov 2023
13 202318039356-FORM 3 [06-12-2023(online)].pdf 06 Dec 2023